Do’s and Don’ts” for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?
Intra-arterial chemotherapy (IAC) has emerged as the primary treatment option for retinoblastoma management. It enables the localized delivery of a higher concentration of chemotherapeutic agents (melphalan, carboplatin and topotecan) in the ophthalmic artery, enhancing tumour control and potentiall...
Saved in:
Main Authors: | Pallav Bhatter, Rajsrinivas Parthasarathy, Vipul Gupta, Srinivas Rao Dusa, Ujjwal Aggarwal, Sima Das, Pallav Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/IJO.IJO_2912_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retinoblastoma Morphology after Local Chemotherapy
by: S. V. Saakyan, et al.
Published: (2021-10-01) -
Hidden Culprit: Middle Cerebral Artery Fenestration as an Overlooked Cause of Stroke in a 4 Year Old
by: Pallav Bhatter, et al.
Published: (2025-05-01) -
Refractive Errors in Children with Retinoblastoma
by: S. V. Saakyan, et al.
Published: (2020-04-01) -
Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study
by: Mohammad Faranoush, et al.
Published: (2025-05-01) -
Retinopathy of prematurity and retinoblastoma: materials of the scientific and practical conference
by: artiсle Editorial
Published: (2019-08-01)